Therapeutic Solutions International Inc. Reports Revenues Up 850% for Q2
August 29, 2019 13:53 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire - Therapeutics Solutions International Inc. (OTC: TSOI) today reports that its second-quarter 2019 revenues increased 850%, as...
Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System in Advanced Cancer Patients
August 26, 2019 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today positive results from a pilot clinical trial...
NanoStilbene™ Nutraceutical Shown to Increase Ability of Cyclophosphamide Chemotherapy to Suppress Cancer
July 29, 2019 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- NetworkWire – Therapeutics Solutions International, Inc., (OTC Markets: TSOI) reported today positive animal data demonstrating synergy at...
Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Cancer Immunotherapy in Animal Model of Cancer
July 22, 2019 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc. (OTC Markets: TSOI) reported today positive animal data demonstrating synergy...
Therapeutic Solutions International, Inc., Announces the Appointment of Nassir Azimi, MD, to Science Board
May 09, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company to Initiate Investigational Cardiovascular Study with Dr. Azimi and NanoStilbene OCEANSIDE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International,...
Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment Centers
May 01, 2018 09:00 ET
|
Therapeutic Solutions International, Inc.
Company Aims to Leverage Transfer Factor Pulsed Autologous Dendritic Cells on StemVacs Platform withPatented Augmenter of Cancer Immunotherapy NanoStilbene OCEANSIDE, Calif., May 01, 2018 ...